Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patients / M. Stork ... [et al.]. -- ilustr., grafy, tab. -- Bibliogr. odkazy - Res. angl.

In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2018. -- s. 477-649. -- ISSN 0028-2685. -- Vol. 65, no. 4 (2018), s. 585-591

1. myelóm mnohopočetný - farmakoterapia - terapia 2. farmakoterapia - metódy 3. recidíva 4. prežívanie bez choroby

I. Štork, M.
II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 65, no. 4 (2018), s. 585-591

lenalidomid - použitie terapeutické, účinky nežiaduce - daratumumab - pomalidomid